bezafibrate has been researched along with Metastase in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, C; Dai, M; Li, H; Wang, D; Wang, W; Wu, L | 1 |
Capdevila, JH; Chen, X; Falck, JR; Gangadhariah, M; Hu, W; Jat, JL; Mont, S; Pozzi, A; Skrypnyk, N; Su, Y; Wei, S; Yang, S; Zent, R | 1 |
2 other study(ies) available for bezafibrate and Metastase
Article | Year |
---|---|
PPARĪ± ligand, AVE8134, and cyclooxygenase inhibitor therapy synergistically suppress lung cancer growth and metastasis.
Topics: Animals; Antineoplastic Agents; Benzoates; Bezafibrate; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cyclooxygenase Inhibitors; Cytochrome P450 Family 2; Drug Evaluation, Preclinical; Drug Therapy, Combination; Eicosanoids; Indomethacin; Lung Neoplasms; Mice; Mice, Inbred C57BL; Mice, Knockout; Neoplasm Metastasis; Neovascularization, Pathologic; Oxazoles; PPAR alpha; Pyrimidines; Treatment Outcome; Xenograft Model Antitumor Assays | 2019 |
PPARĪ± activation can help prevent and treat non-small cell lung cancer.
Topics: Animals; Arachidonic Acids; Bezafibrate; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Cytochrome P-450 Enzyme System; Cytochrome P450 Family 2; Disease Models, Animal; Endothelial Cells; Female; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Male; Mice; Neoplasm Metastasis; Neoplasm Transplantation; Neovascularization, Pathologic; PPAR alpha; Pyrimidines | 2014 |